<HTML><HEAD><TITLE>Gene Ontology Results</TITLE></HEAD><BODY>
<H1>Gene Ontology Enrichment Results</H1>
<A HREF="homerResults.html">Homer <i>de novo</i> Motif Enrichment Results</A><BR/>
<A HREF="knownResults.html">Known Motif Enrichment Results</A><BR/>
<H4>Text file version of complete results (i.e. open with Excel)
<UL>
<LI><A HREF="biological_process.txt">biological process</A>: Functional groupings of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="molecular_function.txt">molecular function</A>: Mechanistic actions of proteins (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="cellular_component.txt">cellular component</A>: Protein localization (<A HREF="http://www.geneontology.org">Gene Ontology</A>)</LI>
<LI><A HREF="chromosome.txt">chromosome location</A>: Genes with similar chromosome localization (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="kegg.txt">KEGG pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.genome.jp/kegg/pathway.html">KEGG</A>)</LI>
<LI><A HREF="interactions.txt">protein interactions</A>: "Proteins interacting with a common protein (BIND, EcoCyc, HPRD)" (<A HREF="http://www.ncbi.nlm.nih.gov/gene">NCBI Gene</A>)</LI>
<LI><A HREF="interpro.txt">interpro domains</A>: Proteins with similar domains and features (<A HREF="http://www.ebi.ac.uk/interpro/">Interpro</A>)</LI>
<LI><A HREF="pfam.txt">pfam domains</A>: Proteins with similar domains and features (<A HREF="http://www.sanger.ac.uk/Software/Pfam/">Pfam</A>)</LI>
<LI><A HREF="smart.txt">smart domains</A>: Proteins with similar domains and features (<A HREF="http://smart.embl-heidelberg.de/">SMART</A>)</LI>
<LI><A HREF="gene3d.txt">gene3d domains</A>: Proteins with similar domains and features (<A HREF="http://cathwww.biochem.ucl.ac.uk:8080/Gene3D">Gene3D</A>)</LI>
<LI><A HREF="prosite.txt">prosite domains</A>: Proteins with similar domains and features (<A HREF="http://ca.expasy.org/prosite/">Prosite</A>)</LI>
<LI><A HREF="prints.txt">prints domains</A>: Proteins with similar domains and features (<A HREF="http://www.bioinf.manchester.ac.uk/dbbrowser/PRINTS/">PRINTS</A>)</LI>
<LI><A HREF="msigdb.txt">MSigDB lists</A>: "Genes sets for pathways, factor/miRNA target predictions, expression patterns, etc." (<A HREF="http://www.broadinstitute.org/gsea/msigdb/index.jsp">MSigDB</A>)</LI>
<LI><A HREF="biocyc.txt">BIOCYC pathways</A>: Groups of proteins in the same pathways (<A HREF="http://biocyc.org/">BIOCYC</A>)</LI>
<LI><A HREF="cosmic.txt">COSMIC cancer mutations</A>: Genes mutated in similar cancers (<A HREF="http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/">COSMIC</A>)</LI>
<LI><A HREF="gwas.txt">GWAS genes</A>: Genes mutated in similar diseases (<A HREF="http://www.genome.gov/26525384">GWAS Catalog</A>)</LI>
<LI><A HREF="lipidmaps.txt">Lipid Maps pathways</A>: Groups of proteins in the same lipid pathways (<A HREF="http://www.ncbi.nlm.nih.gov/biosystems/">Lipid Maps/Biosystems</A>)</LI>
<LI><A HREF="pathwayInteractionDB.txt">Pathway Interaction DB</A>: Groups of proteins in the same pathways (<A HREF="http://pid.nci.nih.gov/">Pathway Interaction Database</A>)</LI>
<LI><A HREF="reactome.txt">REACTOME pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.reactome.org/PathwayBrowser/">REACTOME</A>)</LI>
<LI><A HREF="smpdb.txt">SMPDB pathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.smpdb.ca/">SMPDB</A>)</LI>
<LI><A HREF="wikipathways.txt">WikiPathways</A>: Groups of proteins in the same pathways (<A HREF="http://www.wikipathways.org/index.php/Special:BrowsePathwaysPage">Wikipathways</A>)</LI>
</UL>
<H2>Enriched Categories</H2>
<TABLE border="1" cellpading="0" cellspacing="0">
<TR><TH>P-value</TH><TD>ln(P)</TD><TD>Term</TD><TD>GO Tree</TD><TD>GO ID</TD><TD># of Genes in Term</TD><TD># of Target Genes in Term</TD><TD># of Total Genes</TD><TD># of Target Genes</TD><TD>Common Genes</TD></TR>
<TR><TD>1.885e-04</TD><TD>-8.58</TD><TD>Negative regulation of FGFR3 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654732</TD><TD>10</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>1.885e-04</TD><TD>-8.58</TD><TD>Negative regulation of FGFR2 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654727</TD><TD>10</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>3.795e-04</TD><TD>-7.88</TD><TD>Signaling by FGFR3</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654741</TD><TD>14</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.590e-04</TD><TD>-7.49</TD><TD>SERVITJA_LIVER_HNF1A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SERVITJA_LIVER_HNF1A_TARGETS_UP</TD><TD>27</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>7.877e-04</TD><TD>-7.15</TD><TD>GSE18893_TCONV_VS_TREG_24H_CULTURE_DN</TD><TD>MSigDB lists</TD><TD>GSE18893_TCONV_VS_TREG_24H_CULTURE_DN</TD><TD>32</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>1.270e-03</TD><TD>-6.67</TD><TD>grl-1 (GRound-Like (grd related))</TD><TD>protein interactions</TD><TD>182850</TD><TD>1</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.270e-03</TD><TD>-6.67</TD><TD>F13G3.10 (hypothetical protein)</TD><TD>protein interactions</TD><TD>3565846</TD><TD>1</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.270e-03</TD><TD>-6.67</TD><TD>dkf-1 (Serine/threonine-protein kinase dkf-1)</TD><TD>protein interactions</TD><TD>173234</TD><TD>1</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.293e-03</TD><TD>-6.65</TD><TD>presynaptic endosome</TD><TD>cellular component</TD><TD>GO:0098830</TD><TD>1</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.360e-03</TD><TD>-6.60</TD><TD>GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN</TD><TD>MSigDB lists</TD><TD>GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN</TD><TD>42</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28,toca-1</TD></TR>
<TR><TD>1.360e-03</TD><TD>-6.60</TD><TD>GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN</TD><TD>42</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>1.389e-03</TD><TD>-6.58</TD><TD>O-phospho-L-serine:2-oxoglutarate aminotransferase activity</TD><TD>molecular function</TD><TD>GO:0004648</TD><TD>1</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>C2CD5</TD><TD>interpro domains</TD><TD>IPR038983</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>F52H2.7</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>AP3_complex_dsu</TD><TD>interpro domains</TD><TD>IPR017105</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>C2_C2CD5</TD><TD>interpro domains</TD><TD>IPR037785</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>F52H2.7</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>Pser_aminoTfrase</TD><TD>interpro domains</TD><TD>IPR022278</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>HOPX</TD><TD>interpro domains</TD><TD>IPR039162</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>ceh-89</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>FRS2_PTB</TD><TD>interpro domains</TD><TD>IPR038742</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.409e-03</TD><TD>-6.56</TD><TD>CBD_Afadin</TD><TD>interpro domains</TD><TD>IPR037977</TD><TD>1</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>afd-1</TD></TR>
<TR><TD>1.421e-03</TD><TD>-6.56</TD><TD>MODULE_65</TD><TD>MSigDB lists</TD><TD>MODULE_65</TD><TD>1</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.421e-03</TD><TD>-6.56</TD><TD>GO_CGMP_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_CGMP_BIOSYNTHETIC_PROCESS</TD><TD>1</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.425e-03</TD><TD>-6.55</TD><TD>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</TD><TD>MSigDB lists</TD><TD>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</TD><TD>43</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,gcy-28</TD></TR>
<TR><TD>1.561e-03</TD><TD>-6.46</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP</TD><TD>MSigDB lists</TD><TD>GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP</TD><TD>45</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,toca-1</TD></TR>
<TR><TD>1.702e-03</TD><TD>-6.38</TD><TD>GROSS_HYPOXIA_VIA_ELK3_UP</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_ELK3_UP</TD><TD>47</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,toca-1</TD></TR>
<TR><TD>1.746e-03</TD><TD>-6.35</TD><TD>synaptic vesicle membrane organization</TD><TD>biological process</TD><TD>GO:0048499</TD><TD>1</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.746e-03</TD><TD>-6.35</TD><TD>synaptic vesicle recycling via endosome</TD><TD>biological process</TD><TD>GO:0036466</TD><TD>1</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.746e-03</TD><TD>-6.35</TD><TD>synaptic vesicle endosomal processing</TD><TD>biological process</TD><TD>GO:0099532</TD><TD>1</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.746e-03</TD><TD>-6.35</TD><TD>synaptic vesicle budding from endosome</TD><TD>biological process</TD><TD>GO:0016182</TD><TD>1</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.993e-03</TD><TD>-6.22</TD><TD>IRS_PTB</TD><TD>prosite domains</TD><TD>PS51064</TD><TD>1</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>rog-1</TD></TR>
<TR><TD>2.019e-03</TD><TD>-6.21</TD><TD>PTBI</TD><TD>smart domains</TD><TD>SM00310</TD><TD>1</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>rog-1</TD></TR>
<TR><TD>2.082e-03</TD><TD>-6.17</TD><TD>E4BP4_01</TD><TD>MSigDB lists</TD><TD>E4BP4_01</TD><TD>52</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1,elo-3</TD></TR>
<TR><TD>2.082e-03</TD><TD>-6.17</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</TD><TD>MSigDB lists</TD><TD>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</TD><TD>52</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6,elo-3</TD></TR>
<TR><TD>2.158e-03</TD><TD>-6.14</TD><TD>Signaling by FGFR2</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654738</TD><TD>33</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>2.162e-03</TD><TD>-6.14</TD><TD>GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP</TD><TD>53</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,toca-1</TD></TR>
<TR><TD>2.290e-03</TD><TD>-6.08</TD><TD>Signaling by FGFR</TD><TD>REACTOME pathways</TD><TD>R-CEL-190236</TD><TD>34</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>2.412e-03</TD><TD>-6.03</TD><TD>TTAYRTAA_E4BP4_01</TD><TD>MSigDB lists</TD><TD>TTAYRTAA_E4BP4_01</TD><TD>56</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,toca-1</TD></TR>
<TR><TD>2.574e-03</TD><TD>-5.96</TD><TD>NATPEPTIDER</TD><TD>prints domains</TD><TD>PR00255</TD><TD>3</TD><TD>1</TD><TD>2330</TD><TD>2</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.584e-03</TD><TD>-5.96</TD><TD>AP-3 adaptor complex</TD><TD>cellular component</TD><TD>GO:0030123</TD><TD>2</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.586e-03</TD><TD>-5.96</TD><TD>GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP</TD><TD>MSigDB lists</TD><TD>GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP</TD><TD>58</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,gcy-28</TD></TR>
<TR><TD>2.817e-03</TD><TD>-5.87</TD><TD>IRS_PTB</TD><TD>interpro domains</TD><TD>IPR002404</TD><TD>2</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>rog-1</TD></TR>
<TR><TD>2.817e-03</TD><TD>-5.87</TD><TD>Dilute_dom</TD><TD>interpro domains</TD><TD>IPR002710</TD><TD>2</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>afd-1</TD></TR>
<TR><TD>2.840e-03</TD><TD>-5.86</TD><TD>GO_CGMP_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_CGMP_METABOLIC_PROCESS</TD><TD>2</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.840e-03</TD><TD>-5.86</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN</TD><TD>MSigDB lists</TD><TD>SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN</TD><TD>2</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.840e-03</TD><TD>-5.86</TD><TD>MODULE_445</TD><TD>MSigDB lists</TD><TD>MODULE_445</TD><TD>2</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.840e-03</TD><TD>-5.86</TD><TD>GO_FATTY_ACID_ELONGATION</TD><TD>MSigDB lists</TD><TD>GO_FATTY_ACID_ELONGATION</TD><TD>2</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.982e-03</TD><TD>-5.82</TD><TD>IRS</TD><TD>pfam domains</TD><TD>PF02174</TD><TD>2</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>rog-1</TD></TR>
<TR><TD>2.982e-03</TD><TD>-5.82</TD><TD>DIL</TD><TD>pfam domains</TD><TD>PF01843</TD><TD>2</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>afd-1</TD></TR>
<TR><TD>3.144e-03</TD><TD>-5.76</TD><TD>GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN</TD><TD>64</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>3.288e-03</TD><TD>-5.72</TD><TD>Serine biosynthesis, glycerate-3P => serine</TD><TD>KEGG pathways</TD><TD>M00020</TD><TD>3</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.288e-03</TD><TD>-5.72</TD><TD>Vitamin B6 metabolism</TD><TD>KEGG pathways</TD><TD>ko00750</TD><TD>3</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.288e-03</TD><TD>-5.72</TD><TD>Vitamin B6 metabolism</TD><TD>KEGG pathways</TD><TD>cel00750</TD><TD>3</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.288e-03</TD><TD>-5.72</TD><TD>Serine biosynthesis, glycerate-3P => serine</TD><TD>KEGG pathways</TD><TD>cel_M00020</TD><TD>3</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.481e-03</TD><TD>-5.66</TD><TD>cell-cell junction</TD><TD>cellular component</TD><TD>GO:0005911</TD><TD>69</TD><TD>2</TD><TD>11604</TD><TD>15</TD>
<TD>toca-1,afd-1</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>negative regulation of protein localization to cell-cell adherens junction</TD><TD>biological process</TD><TD>GO:1904703</TD><TD>2</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>synaptic vesicle cytoskeletal transport</TD><TD>biological process</TD><TD>GO:0099514</TD><TD>2</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>synaptic vesicle transport along microtubule</TD><TD>biological process</TD><TD>GO:0099517</TD><TD>2</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>regulation of protein localization to cell-cell adherens junction</TD><TD>biological process</TD><TD>GO:1904702</TD><TD>2</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>anterograde synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:0048490</TD><TD>2</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>3.488e-03</TD><TD>-5.66</TD><TD>L-serine biosynthetic process</TD><TD>biological process</TD><TD>GO:0006564</TD><TD>2</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.544e-03</TD><TD>-5.64</TD><TD>MEISSNER_NPC_HCP_WITH_H3K4ME2</TD><TD>MSigDB lists</TD><TD>MEISSNER_NPC_HCP_WITH_H3K4ME2</TD><TD>68</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28,tbc-6</TD></TR>
<TR><TD>3.753e-03</TD><TD>-5.59</TD><TD>HELLER_HDAC_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>HELLER_HDAC_TARGETS_DN</TD><TD>70</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>3.805e-03</TD><TD>-5.57</TD><TD>cav-1 (Caveolin;Caveolin-1)</TD><TD>protein interactions</TD><TD>177815</TD><TD>3</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.983e-03</TD><TD>-5.53</TD><TD>DILUTE</TD><TD>prosite domains</TD><TD>PS51126</TD><TD>2</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>afd-1</TD></TR>
<TR><TD>3.983e-03</TD><TD>-5.53</TD><TD>REM_1</TD><TD>prosite domains</TD><TD>PS51860</TD><TD>2</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.034e-03</TD><TD>-5.51</TD><TD>DIL</TD><TD>smart domains</TD><TD>SM01132</TD><TD>2</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>afd-1</TD></TR>
<TR><TD>4.077e-03</TD><TD>-5.50</TD><TD>GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN</TD><TD>MSigDB lists</TD><TD>GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN</TD><TD>73</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>4.188e-03</TD><TD>-5.48</TD><TD>GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP</TD><TD>74</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>4.188e-03</TD><TD>-5.48</TD><TD>GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN</TD><TD>74</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>4.223e-03</TD><TD>-5.47</TD><TD>Olfac-like_dom</TD><TD>interpro domains</TD><TD>IPR003112</TD><TD>3</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>cof-2</TD></TR>
<TR><TD>4.223e-03</TD><TD>-5.47</TD><TD>ANPR/GUC</TD><TD>interpro domains</TD><TD>IPR001170</TD><TD>3</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.223e-03</TD><TD>-5.47</TD><TD>Aminotrans_V_PyrdxlP_BS</TD><TD>interpro domains</TD><TD>IPR020578</TD><TD>3</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.258e-03</TD><TD>-5.46</TD><TD>GO_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>GO_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE</TD><TD>3</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.258e-03</TD><TD>-5.46</TD><TD>chr4q25</TD><TD>MSigDB lists</TD><TD>chr4q25</TD><TD>3</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.258e-03</TD><TD>-5.46</TD><TD>KANG_DOXORUBICIN_RESISTANCE_DN</TD><TD>MSigDB lists</TD><TD>KANG_DOXORUBICIN_RESISTANCE_DN</TD><TD>3</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.470e-03</TD><TD>-5.41</TD><TD>Methyltransf_22</TD><TD>pfam domains</TD><TD>PF13383</TD><TD>3</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>Y55F3AM.11</TD></TR>
<TR><TD>4.470e-03</TD><TD>-5.41</TD><TD>OLF</TD><TD>pfam domains</TD><TD>PF02191</TD><TD>3</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>cof-2</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>RAF/MAP kinase cascade</TD><TD>REACTOME pathways</TD><TD>R-CEL-5673001</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>RET signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-8853659</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>GRB2 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-179812</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>Interleukin receptor SHC signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-912526</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>SOS-mediated signalling</TD><TD>REACTOME pathways</TD><TD>R-CEL-112412</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>Signalling to p38 via RIT and RIN</TD><TD>REACTOME pathways</TD><TD>R-CEL-187706</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>4.725e-03</TD><TD>-5.35</TD><TD>SHC1 events in EGFR signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-180336</TD><TD>49</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>4.917e-03</TD><TD>-5.32</TD><TD>MAPK1/MAPK3 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5684996</TD><TD>50</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>4.917e-03</TD><TD>-5.32</TD><TD>Signaling by Leptin</TD><TD>REACTOME pathways</TD><TD>R-CEL-2586552</TD><TD>50</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>4.917e-03</TD><TD>-5.32</TD><TD>Interleukin-2 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-451927</TD><TD>50</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.112e-03</TD><TD>-5.28</TD><TD>NCAM signaling for neurite out-growth</TD><TD>REACTOME pathways</TD><TD>R-CEL-375165</TD><TD>51</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>5.145e-03</TD><TD>-5.27</TD><TD>UBIQUITIN</TD><TD>prints domains</TD><TD>PR00348</TD><TD>6</TD><TD>1</TD><TD>2330</TD><TD>2</TD>
<TD>ubq-1</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>neurotransmitter receptor transport, postsynaptic endosome to lysosome</TD><TD>biological process</TD><TD>GO:0098943</TD><TD>3</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>protein localization to lysosome</TD><TD>biological process</TD><TD>GO:0061462</TD><TD>3</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>5.228e-03</TD><TD>-5.25</TD><TD>lateral inhibition</TD><TD>biological process</TD><TD>GO:0046331</TD><TD>3</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>5.311e-03</TD><TD>-5.24</TD><TD>Frs2-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-170968</TD><TD>52</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.513e-03</TD><TD>-5.20</TD><TD>Signalling to RAS</TD><TD>REACTOME pathways</TD><TD>R-CEL-167044</TD><TD>53</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.513e-03</TD><TD>-5.20</TD><TD>ARMS-mediated activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-170984</TD><TD>53</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.674e-03</TD><TD>-5.17</TD><TD>HUMMEL_BURKITTS_LYMPHOMA_DN</TD><TD>MSigDB lists</TD><TD>HUMMEL_BURKITTS_LYMPHOMA_DN</TD><TD>4</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>5.674e-03</TD><TD>-5.17</TD><TD>GO_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS</TD><TD>4</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>5.674e-03</TD><TD>-5.17</TD><TD>SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP</TD><TD>MSigDB lists</TD><TD>SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP</TD><TD>4</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>5.674e-03</TD><TD>-5.17</TD><TD>GO_CYCLASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_CYCLASE_ACTIVITY</TD><TD>4</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>5.719e-03</TD><TD>-5.16</TD><TD>Prolonged ERK activation events</TD><TD>REACTOME pathways</TD><TD>R-CEL-169893</TD><TD>54</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.719e-03</TD><TD>-5.16</TD><TD>Interleukin-3, 5 and GM-CSF signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-512988</TD><TD>54</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>5.719e-03</TD><TD>-5.16</TD><TD>VEGFR2 mediated cell proliferation</TD><TD>REACTOME pathways</TD><TD>R-CEL-5218921</TD><TD>54</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>5.929e-03</TD><TD>-5.13</TD><TD>MAPK family signaling cascades</TD><TD>REACTOME pathways</TD><TD>R-CEL-5683057</TD><TD>55</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>5.968e-03</TD><TD>-5.12</TD><TD>OLF</TD><TD>prosite domains</TD><TD>PS51132</TD><TD>3</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>cof-2</TD></TR>
<TR><TD>5.968e-03</TD><TD>-5.12</TD><TD>AA_TRANSFER_CLASS_5</TD><TD>prosite domains</TD><TD>PS00595</TD><TD>3</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>6.046e-03</TD><TD>-5.11</TD><TD>OLF</TD><TD>smart domains</TD><TD>SM00284</TD><TD>3</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>cof-2</TD></TR>
<TR><TD>6.336e-03</TD><TD>-5.06</TD><TD>lin-23 (F-box/WD repeat-containing protein lin-23)</TD><TD>protein interactions</TD><TD>174058</TD><TD>5</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>6.358e-03</TD><TD>-5.06</TD><TD>FCERI mediated MAPK activation</TD><TD>REACTOME pathways</TD><TD>R-CEL-2871796</TD><TD>57</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>6.426e-03</TD><TD>-5.05</TD><TD>Ubiquitin-like_domsf</TD><TD>interpro domains</TD><TD>IPR029071</TD><TD>86</TD><TD>2</TD><TD>14190</TD><TD>20</TD>
<TD>ubq-1,afd-1</TD></TR>
<TR><TD>6.579e-03</TD><TD>-5.02</TD><TD>Signalling to ERKs</TD><TD>REACTOME pathways</TD><TD>R-CEL-187687</TD><TD>58</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>6.965e-03</TD><TD>-4.97</TD><TD>synaptic vesicle budding</TD><TD>biological process</TD><TD>GO:0070142</TD><TD>4</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>6.965e-03</TD><TD>-4.97</TD><TD>anterograde axonal transport</TD><TD>biological process</TD><TD>GO:0008089</TD><TD>4</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>7.028e-03</TD><TD>-4.96</TD><TD>Ubiquitin_CS</TD><TD>interpro domains</TD><TD>IPR019954</TD><TD>5</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>ubq-1</TD></TR>
<TR><TD>7.028e-03</TD><TD>-4.96</TD><TD>DUF1280</TD><TD>interpro domains</TD><TD>IPR009689</TD><TD>5</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>T07F8.1</TD></TR>
<TR><TD>7.088e-03</TD><TD>-4.95</TD><TD>GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP</TD><TD>5</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>7.088e-03</TD><TD>-4.95</TD><TD>MAHADEVAN_RESPONSE_TO_MP470_UP</TD><TD>MSigDB lists</TD><TD>MAHADEVAN_RESPONSE_TO_MP470_UP</TD><TD>5</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>7.088e-03</TD><TD>-4.95</TD><TD>CONRAD_STEM_CELL</TD><TD>MSigDB lists</TD><TD>CONRAD_STEM_CELL</TD><TD>5</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>7.088e-03</TD><TD>-4.95</TD><TD>FIGUEROA_AML_METHYLATION_CLUSTER_6_DN</TD><TD>MSigDB lists</TD><TD>FIGUEROA_AML_METHYLATION_CLUSTER_6_DN</TD><TD>5</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>7.413e-03</TD><TD>-4.90</TD><TD>WANG_SMARCE1_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>WANG_SMARCE1_TARGETS_DN</TD><TD>99</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,tbc-6</TD></TR>
<TR><TD>7.440e-03</TD><TD>-4.90</TD><TD>DUF1280</TD><TD>pfam domains</TD><TD>PF06918</TD><TD>5</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>T07F8.1</TD></TR>
<TR><TD>7.440e-03</TD><TD>-4.90</TD><TD>FCH</TD><TD>pfam domains</TD><TD>PF00611</TD><TD>5</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>toca-1</TD></TR>
<TR><TD>7.599e-03</TD><TD>-4.88</TD><TD>chn-1 (C-term of Hsp70-iNteracting protein (CHIP family))</TD><TD>protein interactions</TD><TD>172303</TD><TD>6</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>7.661e-03</TD><TD>-4.87</TD><TD>cGMP signaling</TD><TD>KEGG pathways</TD><TD>M00694</TD><TD>7</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>gcy-28</TD></TR>
<TR><TD>7.661e-03</TD><TD>-4.87</TD><TD>cGMP signaling</TD><TD>KEGG pathways</TD><TD>cel_M00694</TD><TD>7</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>gcy-28</TD></TR>
<TR><TD>7.733e-03</TD><TD>-4.86</TD><TD>terminal bouton</TD><TD>cellular component</TD><TD>GO:0043195</TD><TD>6</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>8.216e-03</TD><TD>-4.80</TD><TD>Signaling by Interleukins</TD><TD>REACTOME pathways</TD><TD>R-CEL-449147</TD><TD>65</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>8.428e-03</TD><TD>-4.78</TD><TD>ELO_CS</TD><TD>interpro domains</TD><TD>IPR030457</TD><TD>6</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>elo-3</TD></TR>
<TR><TD>8.428e-03</TD><TD>-4.78</TD><TD>Ubiquitin</TD><TD>interpro domains</TD><TD>IPR019956</TD><TD>6</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>ubq-1</TD></TR>
<TR><TD>8.501e-03</TD><TD>-4.77</TD><TD>chr9p21</TD><TD>MSigDB lists</TD><TD>chr9p21</TD><TD>6</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>8.501e-03</TD><TD>-4.77</TD><TD>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</TD><TD>MSigDB lists</TD><TD>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</TD><TD>6</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>8.501e-03</TD><TD>-4.77</TD><TD>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN</TD><TD>MSigDB lists</TD><TD>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN</TD><TD>6</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>8.501e-03</TD><TD>-4.77</TD><TD>LIU_VAV3_PROSTATE_CARCINOGENESIS_DN</TD><TD>MSigDB lists</TD><TD>LIU_VAV3_PROSTATE_CARCINOGENESIS_DN</TD><TD>6</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>8.501e-03</TD><TD>-4.77</TD><TD>GCM_AQP4</TD><TD>MSigDB lists</TD><TD>GCM_AQP4</TD><TD>6</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>8.699e-03</TD><TD>-4.74</TD><TD>histone H3-K27 demethylation</TD><TD>biological process</TD><TD>GO:0071557</TD><TD>5</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>8.699e-03</TD><TD>-4.74</TD><TD>cell-cell signaling involved in cell fate commitment</TD><TD>biological process</TD><TD>GO:0045168</TD><TD>5</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>8.715e-03</TD><TD>-4.74</TD><TD>Signaling by SCF-KIT</TD><TD>REACTOME pathways</TD><TD>R-CEL-1433557</TD><TD>67</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>8.784e-03</TD><TD>-4.73</TD><TD>HALLMARK_MTORC1_SIGNALING</TD><TD>MSigDB lists</TD><TD>HALLMARK_MTORC1_SIGNALING</TD><TD>108</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>8.852e-03</TD><TD>-4.73</TD><TD>Negative regulation of FGFR4 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654733</TD><TD>4</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>8.861e-03</TD><TD>-4.73</TD><TD>rpn-1 (26S proteasome non-ATPase regulatory subunit 2)</TD><TD>protein interactions</TD><TD>177455</TD><TD>7</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>9.016e-03</TD><TD>-4.71</TD><TD>axon terminus</TD><TD>cellular component</TD><TD>GO:0043679</TD><TD>7</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>9.228e-03</TD><TD>-4.69</TD><TD>Signaling by VEGF</TD><TD>REACTOME pathways</TD><TD>R-CEL-194138</TD><TD>69</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>9.228e-03</TD><TD>-4.69</TD><TD>VEGFA-VEGFR2 Pathway</TD><TD>REACTOME pathways</TD><TD>R-CEL-4420097</TD><TD>69</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>9.754e-03</TD><TD>-4.63</TD><TD>Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)</TD><TD>REACTOME pathways</TD><TD>R-CEL-2404192</TD><TD>71</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>9.754e-03</TD><TD>-4.63</TD><TD>Insulin receptor signalling cascade</TD><TD>REACTOME pathways</TD><TD>R-CEL-74751</TD><TD>71</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>9.754e-03</TD><TD>-4.63</TD><TD>IRS-mediated signalling</TD><TD>REACTOME pathways</TD><TD>R-CEL-112399</TD><TD>71</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>9.754e-03</TD><TD>-4.63</TD><TD>Gastrin-CREB signalling pathway via PKC and MAPK</TD><TD>REACTOME pathways</TD><TD>R-CEL-881907</TD><TD>71</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>9.754e-03</TD><TD>-4.63</TD><TD>IGF1R signaling cascade</TD><TD>REACTOME pathways</TD><TD>R-CEL-2428924</TD><TD>71</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>9.754e-03</TD><TD>-4.63</TD><TD>IRS-related events triggered by IGF1R</TD><TD>REACTOME pathways</TD><TD>R-CEL-2428928</TD><TD>71</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>9.827e-03</TD><TD>-4.62</TD><TD>F_BAR</TD><TD>interpro domains</TD><TD>IPR031160</TD><TD>7</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>toca-1</TD></TR>
<TR><TD>9.827e-03</TD><TD>-4.62</TD><TD>Clathrin/coatomer_adapt-like_N</TD><TD>interpro domains</TD><TD>IPR002553</TD><TD>7</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>apd-3</TD></TR>
<TR><TD>9.827e-03</TD><TD>-4.62</TD><TD>FCH_dom</TD><TD>interpro domains</TD><TD>IPR001060</TD><TD>7</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>toca-1</TD></TR>
<TR><TD>9.827e-03</TD><TD>-4.62</TD><TD>Aminotrans_V_dom</TD><TD>interpro domains</TD><TD>IPR000192</TD><TD>7</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>PATTERSON_DOCETAXEL_RESISTANCE</TD><TD>MSigDB lists</TD><TD>PATTERSON_DOCETAXEL_RESISTANCE</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>GO_REGULATION_OF_MEIOTIC_CELL_CYCLE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_MEIOTIC_CELL_CYCLE</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>GO_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_ARF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8</TD><TD>MSigDB lists</TD><TD>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>chr13q34</TD><TD>MSigDB lists</TD><TD>chr13q34</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>MATZUK_CENTRAL_FOR_FEMALE_FERTILITY</TD><TD>MSigDB lists</TD><TD>MATZUK_CENTRAL_FOR_FEMALE_FERTILITY</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>GO_REGULATION_OF_CELL_MATURATION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CELL_MATURATION</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>9.912e-03</TD><TD>-4.61</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN</TD><TD>MSigDB lists</TD><TD>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN</TD><TD>7</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>9.929e-03</TD><TD>-4.61</TD><TD>UBIQUITIN_1</TD><TD>prosite domains</TD><TD>PS00299</TD><TD>5</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.012e-02</TD><TD>-4.59</TD><TD>stam-1 (Signal transducing adapter molecule 1)</TD><TD>protein interactions</TD><TD>172264</TD><TD>8</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.012e-02</TD><TD>-4.59</TD><TD>ufd-2 (Ubiquitin conjugation factor E4 ufd-2)</TD><TD>protein interactions</TD><TD>174295</TD><TD>8</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.030e-02</TD><TD>-4.58</TD><TD>axon cytoplasm</TD><TD>cellular component</TD><TD>GO:1904115</TD><TD>8</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.040e-02</TD><TD>-4.57</TD><TD>Adaptin_N</TD><TD>pfam domains</TD><TD>PF01602</TD><TD>7</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.040e-02</TD><TD>-4.57</TD><TD>Aminotran_5</TD><TD>pfam domains</TD><TD>PF00266</TD><TD>7</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>ectodermal digestive tract development</TD><TD>biological process</TD><TD>GO:0007439</TD><TD>6</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>embryonic ectodermal digestive tract morphogenesis</TD><TD>biological process</TD><TD>GO:0048613</TD><TD>6</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>sensory processing</TD><TD>biological process</TD><TD>GO:0050893</TD><TD>6</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>embryonic ectodermal digestive tract development</TD><TD>biological process</TD><TD>GO:0048611</TD><TD>6</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>ectodermal digestive tract morphogenesis</TD><TD>biological process</TD><TD>GO:0048567</TD><TD>6</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.043e-02</TD><TD>-4.56</TD><TD>Golgi to vacuole transport</TD><TD>biological process</TD><TD>GO:0006896</TD><TD>6</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.061e-02</TD><TD>-4.55</TD><TD>GO_REGULATION_OF_GTPASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_GTPASE_ACTIVITY</TD><TD>119</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1,tbc-6</TD></TR>
<TR><TD>1.105e-02</TD><TD>-4.50</TD><TD>Metalloprotease DUBs</TD><TD>REACTOME pathways</TD><TD>R-CEL-5689901</TD><TD>5</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.105e-02</TD><TD>-4.50</TD><TD>PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1</TD><TD>REACTOME pathways</TD><TD>R-CEL-8849469</TD><TD>5</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.105e-02</TD><TD>-4.50</TD><TD>Serine biosynthesis</TD><TD>REACTOME pathways</TD><TD>R-CEL-977347</TD><TD>5</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.105e-02</TD><TD>-4.50</TD><TD>Negative regulation of FGFR1 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654726</TD><TD>5</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.113e-02</TD><TD>-4.50</TD><TD>DAP12 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-2424491</TD><TD>76</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.113e-02</TD><TD>-4.50</TD><TD>Signaling by PDGF</TD><TD>REACTOME pathways</TD><TD>R-CEL-186797</TD><TD>76</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>1.113e-02</TD><TD>-4.50</TD><TD>Downstream signal transduction</TD><TD>REACTOME pathways</TD><TD>R-CEL-186763</TD><TD>76</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.113e-02</TD><TD>-4.50</TD><TD>DAP12 interactions</TD><TD>REACTOME pathways</TD><TD>R-CEL-2172127</TD><TD>76</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>HU_GENOTOXIC_DAMAGE_24HR</TD><TD>MSigDB lists</TD><TD>HU_GENOTOXIC_DAMAGE_24HR</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</TD><TD>MSigDB lists</TD><TD>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>chr9q21</TD><TD>MSigDB lists</TD><TD>chr9q21</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>GO_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>WIERENGA_STAT5A_TARGETS_GROUP2</TD><TD>MSigDB lists</TD><TD>WIERENGA_STAT5A_TARGETS_GROUP2</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>DOANE_BREAST_CANCER_ESR1_DN</TD><TD>MSigDB lists</TD><TD>DOANE_BREAST_CANCER_ESR1_DN</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.132e-02</TD><TD>-4.48</TD><TD>KIM_TIAL1_TARGETS</TD><TD>MSigDB lists</TD><TD>KIM_TIAL1_TARGETS</TD><TD>8</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.138e-02</TD><TD>-4.48</TD><TD>dcn-1 (Defective in cullin neddylation protein 1)</TD><TD>protein interactions</TD><TD>175556</TD><TD>9</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.141e-02</TD><TD>-4.47</TD><TD>Fc epsilon receptor (FCERI) signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-2454202</TD><TD>77</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.188e-02</TD><TD>-4.43</TD><TD>RA</TD><TD>pfam domains</TD><TD>PF00788</TD><TD>8</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>afd-1</TD></TR>
<TR><TD>1.190e-02</TD><TD>-4.43</TD><TD>ELO</TD><TD>prosite domains</TD><TD>PS01188</TD><TD>6</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.216e-02</TD><TD>-4.41</TD><TD>vesicle transport along microtubule</TD><TD>biological process</TD><TD>GO:0047496</TD><TD>7</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.216e-02</TD><TD>-4.41</TD><TD>axonal transport</TD><TD>biological process</TD><TD>GO:0098930</TD><TD>7</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.216e-02</TD><TD>-4.41</TD><TD>protein targeting to vacuole</TD><TD>biological process</TD><TD>GO:0006623</TD><TD>7</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>3-oxo-arachidoyl-CoA synthase activity</TD><TD>molecular function</TD><TD>GO:0102336</TD><TD>9</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>3-oxo-lignoceronyl-CoA synthase activity</TD><TD>molecular function</TD><TD>GO:0102338</TD><TD>9</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>fatty acid elongase activity</TD><TD>molecular function</TD><TD>GO:0009922</TD><TD>9</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>very-long-chain 3-ketoacyl-CoA synthase activity</TD><TD>molecular function</TD><TD>GO:0102756</TD><TD>9</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>protein tag</TD><TD>molecular function</TD><TD>GO:0031386</TD><TD>9</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.243e-02</TD><TD>-4.39</TD><TD>3-oxo-cerotoyl-CoA synthase activity</TD><TD>molecular function</TD><TD>GO:0102337</TD><TD>9</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.259e-02</TD><TD>-4.38</TD><TD>LEE_BMP2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>LEE_BMP2_TARGETS_UP</TD><TD>130</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28,toca-1</TD></TR>
<TR><TD>1.262e-02</TD><TD>-4.37</TD><TD>Histone_H1/H5_H15</TD><TD>interpro domains</TD><TD>IPR005818</TD><TD>9</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>hil-8</TD></TR>
<TR><TD>1.262e-02</TD><TD>-4.37</TD><TD>METTL24</TD><TD>interpro domains</TD><TD>IPR026913</TD><TD>9</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>Y55F3AM.11</TD></TR>
<TR><TD>1.262e-02</TD><TD>-4.37</TD><TD>ELO_fam</TD><TD>interpro domains</TD><TD>IPR002076</TD><TD>9</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.262e-02</TD><TD>-4.37</TD><TD>Beta-lactam-related</TD><TD>interpro domains</TD><TD>IPR001466</TD><TD>9</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>lact-1</TD></TR>
<TR><TD>1.273e-02</TD><TD>-4.36</TD><TD>CAHOY_OLIGODENDROCUTIC</TD><TD>MSigDB lists</TD><TD>CAHOY_OLIGODENDROCUTIC</TD><TD>9</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.273e-02</TD><TD>-4.36</TD><TD>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</TD><TD>MSigDB lists</TD><TD>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN</TD><TD>9</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.273e-02</TD><TD>-4.36</TD><TD>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>MSigDB lists</TD><TD>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP</TD><TD>9</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.273e-02</TD><TD>-4.36</TD><TD>KRIGE_AMINO_ACID_DEPRIVATION</TD><TD>MSigDB lists</TD><TD>KRIGE_AMINO_ACID_DEPRIVATION</TD><TD>9</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.273e-02</TD><TD>-4.36</TD><TD>HORTON_SREBF_TARGETS</TD><TD>MSigDB lists</TD><TD>HORTON_SREBF_TARGETS</TD><TD>9</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.286e-02</TD><TD>-4.35</TD><TD>neuron projection cytoplasm</TD><TD>cellular component</TD><TD>GO:0120111</TD><TD>10</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.325e-02</TD><TD>-4.32</TD><TD>Linoleic acid (LA) metabolism</TD><TD>REACTOME pathways</TD><TD>R-CEL-2046105</TD><TD>6</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.325e-02</TD><TD>-4.32</TD><TD>FRS-mediated FGFR3 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654706</TD><TD>6</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.325e-02</TD><TD>-4.32</TD><TD>FRS-mediated FGFR2 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654700</TD><TD>6</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.325e-02</TD><TD>-4.32</TD><TD>FRS-mediated FGFR1 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654693</TD><TD>6</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.325e-02</TD><TD>-4.32</TD><TD>FRS-mediated FGFR4 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654712</TD><TD>6</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.335e-02</TD><TD>-4.32</TD><TD>Linker_histone</TD><TD>pfam domains</TD><TD>PF00538</TD><TD>9</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>hil-8</TD></TR>
<TR><TD>1.335e-02</TD><TD>-4.32</TD><TD>Beta-lactamase</TD><TD>pfam domains</TD><TD>PF00144</TD><TD>9</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>lact-1</TD></TR>
<TR><TD>1.335e-02</TD><TD>-4.32</TD><TD>ELO</TD><TD>pfam domains</TD><TD>PF01151</TD><TD>9</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.387e-02</TD><TD>-4.28</TD><TD>F_BAR</TD><TD>prosite domains</TD><TD>PS51741</TD><TD>7</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.388e-02</TD><TD>-4.28</TD><TD>neurotransmitter receptor transport</TD><TD>biological process</TD><TD>GO:0099637</TD><TD>8</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.388e-02</TD><TD>-4.28</TD><TD>vesicle cytoskeletal trafficking</TD><TD>biological process</TD><TD>GO:0099518</TD><TD>8</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.401e-02</TD><TD>-4.27</TD><TD>RA_dom</TD><TD>interpro domains</TD><TD>IPR000159</TD><TD>10</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>afd-1</TD></TR>
<TR><TD>1.406e-02</TD><TD>-4.26</TD><TD>FCH</TD><TD>smart domains</TD><TD>SM00055</TD><TD>7</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.407e-02</TD><TD>-4.26</TD><TD>endosome</TD><TD>cellular component</TD><TD>GO:0005768</TD><TD>142</TD><TD>2</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3,toca-1</TD></TR>
<TR><TD>1.412e-02</TD><TD>-4.26</TD><TD>Cytokine Signaling in Immune system</TD><TD>REACTOME pathways</TD><TD>R-CEL-1280215</TD><TD>86</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.412e-02</TD><TD>-4.26</TD><TD>Signaling by EGFR</TD><TD>REACTOME pathways</TD><TD>R-CEL-177929</TD><TD>86</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>1.414e-02</TD><TD>-4.26</TD><TD>BRUNO_HEMATOPOIESIS</TD><TD>MSigDB lists</TD><TD>BRUNO_HEMATOPOIESIS</TD><TD>10</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.414e-02</TD><TD>-4.26</TD><TD>REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS</TD><TD>MSigDB lists</TD><TD>REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS</TD><TD>10</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.414e-02</TD><TD>-4.26</TD><TD>OHGUCHI_LIVER_HNF4A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>OHGUCHI_LIVER_HNF4A_TARGETS_UP</TD><TD>10</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.414e-02</TD><TD>-4.26</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</TD><TD>MSigDB lists</TD><TD>TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP</TD><TD>10</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.414e-02</TD><TD>-4.26</TD><TD>GNF2_CBFB</TD><TD>MSigDB lists</TD><TD>GNF2_CBFB</TD><TD>10</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.414e-02</TD><TD>-4.26</TD><TD>AAGGGAT_MIR188</TD><TD>MSigDB lists</TD><TD>AAGGGAT_MIR188</TD><TD>10</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.452e-02</TD><TD>-4.23</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</TD><TD>MSigDB lists</TD><TD>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</TD><TD>140</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28,toca-1</TD></TR>
<TR><TD>1.483e-02</TD><TD>-4.21</TD><TD>FHA</TD><TD>pfam domains</TD><TD>PF00498</TD><TD>10</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>afd-1</TD></TR>
<TR><TD>1.483e-02</TD><TD>-4.21</TD><TD>DUF229</TD><TD>pfam domains</TD><TD>PF02995</TD><TD>10</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>Y73F8A.35</TD></TR>
<TR><TD>1.483e-02</TD><TD>-4.21</TD><TD>JmjC</TD><TD>pfam domains</TD><TD>PF02373</TD><TD>10</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>1.508e-02</TD><TD>-4.19</TD><TD>carboxylic acid biosynthetic process</TD><TD>biological process</TD><TD>GO:0046394</TD><TD>109</TD><TD>2</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>1.515e-02</TD><TD>-4.19</TD><TD>zen-4 (Kinesin-like protein)</TD><TD>protein interactions</TD><TD>177374</TD><TD>12</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.533e-02</TD><TD>-4.18</TD><TD>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</TD><TD>MSigDB lists</TD><TD>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</TD><TD>144</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,gcy-28</TD></TR>
<TR><TD>1.535e-02</TD><TD>-4.18</TD><TD>organic acid biosynthetic process</TD><TD>biological process</TD><TD>GO:0016053</TD><TD>110</TD><TD>2</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>1.540e-02</TD><TD>-4.17</TD><TD>Methyltranfer_dom</TD><TD>interpro domains</TD><TD>IPR025714</TD><TD>11</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>Y55F3AM.11</TD></TR>
<TR><TD>1.540e-02</TD><TD>-4.17</TD><TD>NGF signalling via TRKA from the plasma membrane</TD><TD>REACTOME pathways</TD><TD>R-CEL-187037</TD><TD>90</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>1.541e-02</TD><TD>-4.17</TD><TD>neuron projection terminus</TD><TD>cellular component</TD><TD>GO:0044306</TD><TD>12</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.545e-02</TD><TD>-4.17</TD><TD>TRAF6 mediated induction of TAK1 complex</TD><TD>REACTOME pathways</TD><TD>R-CEL-937072</TD><TD>7</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.545e-02</TD><TD>-4.17</TD><TD>IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation</TD><TD>REACTOME pathways</TD><TD>R-CEL-975163</TD><TD>7</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.545e-02</TD><TD>-4.17</TD><TD>IRAK2 mediated activation of TAK1 complex</TD><TD>REACTOME pathways</TD><TD>R-CEL-937042</TD><TD>7</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.545e-02</TD><TD>-4.17</TD><TD>Downregulation of ERBB4 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-1253288</TD><TD>7</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>GO_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS</TD><TD>11</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.554e-02</TD><TD>-4.16</TD><TD>MODULE_285</TD><TD>MSigDB lists</TD><TD>MODULE_285</TD><TD>11</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.561e-02</TD><TD>-4.16</TD><TD>fatty acid elongation, saturated fatty acid</TD><TD>biological process</TD><TD>GO:0019367</TD><TD>9</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.561e-02</TD><TD>-4.16</TD><TD>fatty acid elongation, monounsaturated fatty acid</TD><TD>biological process</TD><TD>GO:0034625</TD><TD>9</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.561e-02</TD><TD>-4.16</TD><TD>fatty acid elongation, unsaturated fatty acid</TD><TD>biological process</TD><TD>GO:0019368</TD><TD>9</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.561e-02</TD><TD>-4.16</TD><TD>fatty acid elongation, polyunsaturated fatty acid</TD><TD>biological process</TD><TD>GO:0034626</TD><TD>9</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.561e-02</TD><TD>-4.16</TD><TD>positive regulation of clathrin-dependent endocytosis</TD><TD>biological process</TD><TD>GO:2000370</TD><TD>9</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.584e-02</TD><TD>-4.15</TD><TD>H15</TD><TD>prosite domains</TD><TD>PS51504</TD><TD>8</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>hil-8</TD></TR>
<TR><TD>1.607e-02</TD><TD>-4.13</TD><TD>Signaling by Insulin receptor</TD><TD>REACTOME pathways</TD><TD>R-CEL-74752</TD><TD>92</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.655e-02</TD><TD>-4.10</TD><TD>fatty acid synthase activity</TD><TD>molecular function</TD><TD>GO:0004312</TD><TD>12</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.668e-02</TD><TD>-4.09</TD><TD>distal axon</TD><TD>cellular component</TD><TD>GO:0150034</TD><TD>13</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>1.679e-02</TD><TD>-4.09</TD><TD>PAW_sf</TD><TD>interpro domains</TD><TD>IPR038680</TD><TD>12</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>1.679e-02</TD><TD>-4.09</TD><TD>DUF229</TD><TD>interpro domains</TD><TD>IPR004245</TD><TD>12</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>Y73F8A.35</TD></TR>
<TR><TD>1.679e-02</TD><TD>-4.09</TD><TD>Beta-lactam/transpept-like</TD><TD>interpro domains</TD><TD>IPR012338</TD><TD>12</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>lact-1</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>YU_BAP1_TARGETS</TD><TD>MSigDB lists</TD><TD>YU_BAP1_TARGETS</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>chr9p13</TD><TD>MSigDB lists</TD><TD>chr9p13</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</TD><TD>MSigDB lists</TD><TD>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>HUANG_FOXA2_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>HUANG_FOXA2_TARGETS_UP</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>CAGGGTC_MIR504</TD><TD>MSigDB lists</TD><TD>CAGGGTC_MIR504</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>AATGGAG_MIR136</TD><TD>MSigDB lists</TD><TD>AATGGAG_MIR136</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.694e-02</TD><TD>-4.08</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</TD><TD>MSigDB lists</TD><TD>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</TD><TD>12</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.722e-02</TD><TD>-4.06</TD><TD>GO_ORGANIC_ACID_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_ORGANIC_ACID_BIOSYNTHETIC_PROCESS</TD><TD>153</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>1.733e-02</TD><TD>-4.06</TD><TD>regulation of clathrin-dependent endocytosis</TD><TD>biological process</TD><TD>GO:2000369</TD><TD>10</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>1.750e-02</TD><TD>-4.05</TD><TD>-</TD><TD>gene3d domains</TD><TD>2.60.120.1020</TD><TD>12</TD><TD>1</TD><TD>5448</TD><TD>8</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>Downstream signaling of activated FGFR4</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654716</TD><TD>8</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>Degradation of DVL</TD><TD>REACTOME pathways</TD><TD>R-CEL-4641258</TD><TD>8</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>Downstream signaling of activated FGFR1</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654687</TD><TD>8</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>Downstream signaling of activated FGFR2</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654696</TD><TD>8</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.764e-02</TD><TD>-4.04</TD><TD>Downstream signaling of activated FGFR3</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654708</TD><TD>8</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.766e-02</TD><TD>-4.04</TD><TD>thoc-2 (THO Complex (transcription factor/nuclear export) subunit)</TD><TD>protein interactions</TD><TD>175900</TD><TD>14</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.788e-02</TD><TD>-4.02</TD><TD>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</TD><TD>MSigDB lists</TD><TD>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</TD><TD>156</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>1.804e-02</TD><TD>-4.02</TD><TD>RA</TD><TD>smart domains</TD><TD>SM00314</TD><TD>9</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>afd-1</TD></TR>
<TR><TD>1.835e-02</TD><TD>-4.00</TD><TD>GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN</TD><TD>MSigDB lists</TD><TD>GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN</TD><TD>13</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>1.835e-02</TD><TD>-4.00</TD><TD>HOWLIN_PUBERTAL_MAMMARY_GLAND</TD><TD>MSigDB lists</TD><TD>HOWLIN_PUBERTAL_MAMMARY_GLAND</TD><TD>13</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.835e-02</TD><TD>-4.00</TD><TD>REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS</TD><TD>MSigDB lists</TD><TD>REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS</TD><TD>13</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.920e-02</TD><TD>-3.95</TD><TD>Axon guidance</TD><TD>REACTOME pathways</TD><TD>R-CEL-422475</TD><TD>101</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1,rog-1</TD></TR>
<TR><TD>1.956e-02</TD><TD>-3.93</TD><TD>Peptide_N_glycanase_PAW_dom</TD><TD>interpro domains</TD><TD>IPR006588</TD><TD>14</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>1.956e-02</TD><TD>-3.93</TD><TD>JmjC_dom</TD><TD>interpro domains</TD><TD>IPR003347</TD><TD>14</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>1.975e-02</TD><TD>-3.92</TD><TD>CERVERA_SDHB_TARGETS_2</TD><TD>MSigDB lists</TD><TD>CERVERA_SDHB_TARGETS_2</TD><TD>14</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.975e-02</TD><TD>-3.92</TD><TD>GO_PEPTIDE_HORMONE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_PEPTIDE_HORMONE_BINDING</TD><TD>14</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>1.975e-02</TD><TD>-3.92</TD><TD>SMIRNOV_RESPONSE_TO_IR_6HR_DN</TD><TD>MSigDB lists</TD><TD>SMIRNOV_RESPONSE_TO_IR_6HR_DN</TD><TD>14</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.975e-02</TD><TD>-3.92</TD><TD>GSE2706_R848_VS_LPS_2H_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_R848_VS_LPS_2H_STIM_DC_DN</TD><TD>14</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>1.975e-02</TD><TD>-3.92</TD><TD>GO_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS</TD><TD>14</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>1.975e-02</TD><TD>-3.92</TD><TD>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</TD><TD>MSigDB lists</TD><TD>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</TD><TD>14</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>1.977e-02</TD><TD>-3.92</TD><TD>RA</TD><TD>prosite domains</TD><TD>PS50200</TD><TD>10</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>afd-1</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>Negative regulators of RIG-I/MDA5 signaling</TD><TD>REACTOME pathways</TD><TD>R-CEL-936440</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>Signaling by FGFR4</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654743</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription</TD><TD>REACTOME pathways</TD><TD>R-CEL-2173796</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer</TD><TD>REACTOME pathways</TD><TD>R-CEL-2173793</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>Signaling by TGF-beta Receptor Complex</TD><TD>REACTOME pathways</TD><TD>R-CEL-170834</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>1.982e-02</TD><TD>-3.92</TD><TD>RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways</TD><TD>REACTOME pathways</TD><TD>R-CEL-168928</TD><TD>9</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.064e-02</TD><TD>-3.88</TD><TD>peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity</TD><TD>molecular function</TD><TD>GO:0000224</TD><TD>15</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>2.076e-02</TD><TD>-3.87</TD><TD>very long-chain fatty acid biosynthetic process</TD><TD>biological process</TD><TD>GO:0042761</TD><TD>12</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.114e-02</TD><TD>-3.86</TD><TD>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3</TD><TD>MSigDB lists</TD><TD>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3</TD><TD>15</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.114e-02</TD><TD>-3.86</TD><TD>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</TD><TD>MSigDB lists</TD><TD>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</TD><TD>15</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.114e-02</TD><TD>-3.86</TD><TD>GO_PEPTIDE_RECEPTOR_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_PEPTIDE_RECEPTOR_ACTIVITY</TD><TD>15</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.114e-02</TD><TD>-3.86</TD><TD>REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION</TD><TD>MSigDB lists</TD><TD>REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION</TD><TD>15</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.114e-02</TD><TD>-3.86</TD><TD>FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP</TD><TD>MSigDB lists</TD><TD>FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP</TD><TD>15</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.114e-02</TD><TD>-3.86</TD><TD>GO_REGULATION_OF_VESICLE_FUSION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_VESICLE_FUSION</TD><TD>15</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.176e-02</TD><TD>-3.83</TD><TD>AP-type membrane coat adaptor complex</TD><TD>cellular component</TD><TD>GO:0030119</TD><TD>17</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.180e-02</TD><TD>-3.83</TD><TD>Signalling by NGF</TD><TD>REACTOME pathways</TD><TD>R-CEL-166520</TD><TD>108</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>2.200e-02</TD><TD>-3.82</TD><TD>DNA Damage Recognition in GG-NER</TD><TD>REACTOME pathways</TD><TD>R-CEL-5696394</TD><TD>10</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.200e-02</TD><TD>-3.82</TD><TD>Josephin domain DUBs</TD><TD>REACTOME pathways</TD><TD>R-CEL-5689877</TD><TD>10</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.200e-02</TD><TD>-3.82</TD><TD>Signaling by FGFR1</TD><TD>REACTOME pathways</TD><TD>R-CEL-5654736</TD><TD>10</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1</TD></TR>
<TR><TD>2.200e-02</TD><TD>-3.82</TD><TD>Ovarian tumor domain proteases</TD><TD>REACTOME pathways</TD><TD>R-CEL-5689896</TD><TD>10</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.218e-02</TD><TD>-3.81</TD><TD>Developmental Biology</TD><TD>REACTOME pathways</TD><TD>R-CEL-1266738</TD><TD>109</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>2.233e-02</TD><TD>-3.80</TD><TD>FHA_dom</TD><TD>interpro domains</TD><TD>IPR000253</TD><TD>16</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>afd-1</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>L-serine metabolic process</TD><TD>biological process</TD><TD>GO:0006563</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>histone demethylation</TD><TD>biological process</TD><TD>GO:0016577</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>positive regulation of receptor-mediated endocytosis</TD><TD>biological process</TD><TD>GO:0048260</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>establishment of protein localization to vacuole</TD><TD>biological process</TD><TD>GO:0072666</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>axo-dendritic transport</TD><TD>biological process</TD><TD>GO:0008088</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>vesicle budding from membrane</TD><TD>biological process</TD><TD>GO:0006900</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>histone lysine demethylation</TD><TD>biological process</TD><TD>GO:0070076</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>synaptic vesicle recycling</TD><TD>biological process</TD><TD>GO:0036465</TD><TD>13</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.247e-02</TD><TD>-3.80</TD><TD>DNA Replication</TD><TD>WikiPathways</TD><TD>WP192</TD><TD>24</TD><TD>1</TD><TD>1068</TD><TD>1</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>SABATES_COLORECTAL_ADENOMA_UP</TD><TD>MSigDB lists</TD><TD>SABATES_COLORECTAL_ADENOMA_UP</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>BMI1_DN_MEL18_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>BMI1_DN_MEL18_DN.V1_UP</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>GO_VITAMIN_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_VITAMIN_BIOSYNTHETIC_PROCESS</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP</TD><TD>MSigDB lists</TD><TD>GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>MODULE_248</TD><TD>MSigDB lists</TD><TD>MODULE_248</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>ARGGGTTAA_UNKNOWN</TD><TD>MSigDB lists</TD><TD>ARGGGTTAA_UNKNOWN</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.254e-02</TD><TD>-3.79</TD><TD>GO_REGULATION_OF_CARDIAC_CONDUCTION</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_CARDIAC_CONDUCTION</TD><TD>16</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.258e-02</TD><TD>-3.79</TD><TD>regulation of protein localization</TD><TD>biological process</TD><TD>GO:0032880</TD><TD>135</TD><TD>2</TD><TD>9166</TD><TD>16</TD>
<TD>afd-1,toca-1</TD></TR>
<TR><TD>2.266e-02</TD><TD>-3.79</TD><TD>ikb-1 (I Kappa B homolog)</TD><TD>protein interactions</TD><TD>172817</TD><TD>18</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.337e-02</TD><TD>-3.76</TD><TD>cell adhesion molecule binding</TD><TD>molecular function</TD><TD>GO:0050839</TD><TD>17</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>afd-1</TD></TR>
<TR><TD>2.349e-02</TD><TD>-3.75</TD><TD>GO_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY</TD><TD>180</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6,toca-1</TD></TR>
<TR><TD>2.394e-02</TD><TD>-3.73</TD><TD>PIGF_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>PIGF_UP.V1_DN</TD><TD>17</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.394e-02</TD><TD>-3.73</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</TD><TD>MSigDB lists</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</TD><TD>17</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.394e-02</TD><TD>-3.73</TD><TD>ALK_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>ALK_DN.V1_UP</TD><TD>17</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.394e-02</TD><TD>-3.73</TD><TD>KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM</TD><TD>MSigDB lists</TD><TD>KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM</TD><TD>17</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.399e-02</TD><TD>-3.73</TD><TD>JmjC</TD><TD>smart domains</TD><TD>SM00558</TD><TD>12</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.418e-02</TD><TD>-3.72</TD><TD>protein dealkylation</TD><TD>biological process</TD><TD>GO:0008214</TD><TD>14</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.418e-02</TD><TD>-3.72</TD><TD>very long-chain fatty acid metabolic process</TD><TD>biological process</TD><TD>GO:0000038</TD><TD>14</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.418e-02</TD><TD>-3.72</TD><TD>protein demethylation</TD><TD>biological process</TD><TD>GO:0006482</TD><TD>14</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.472e-02</TD><TD>-3.70</TD><TD>transferase activity, transferring nitrogenous groups</TD><TD>molecular function</TD><TD>GO:0016769</TD><TD>18</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.472e-02</TD><TD>-3.70</TD><TD>transaminase activity</TD><TD>molecular function</TD><TD>GO:0008483</TD><TD>18</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>GO_ACTIVATION_OF_GTPASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_ACTIVATION_OF_GTPASE_ACTIVITY</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS</TD><TD>MSigDB lists</TD><TD>KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>GUO_HEX_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>GUO_HEX_TARGETS_UP</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>GO_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS</TD><TD>MSigDB lists</TD><TD>GO_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>GSE2706_R848_VS_LPS_8H_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE2706_R848_VS_LPS_8H_STIM_DC_UP</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</TD><TD>MSigDB lists</TD><TD>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.533e-02</TD><TD>-3.68</TD><TD>JAK2_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>JAK2_DN.V1_UP</TD><TD>18</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.589e-02</TD><TD>-3.65</TD><TD>protein localization to vacuole</TD><TD>biological process</TD><TD>GO:0072665</TD><TD>15</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.589e-02</TD><TD>-3.65</TD><TD>positive regulation of Notch signaling pathway</TD><TD>biological process</TD><TD>GO:0045747</TD><TD>15</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>2.596e-02</TD><TD>-3.65</TD><TD>PAW</TD><TD>smart domains</TD><TD>SM00613</TD><TD>13</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>2.614e-02</TD><TD>-3.64</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.40.720.10</TD><TD>18</TD><TD>1</TD><TD>5448</TD><TD>8</TD>
<TD>Y73F8A.35</TD></TR>
<TR><TD>2.636e-02</TD><TD>-3.64</TD><TD>Translesion synthesis by REV1</TD><TD>REACTOME pathways</TD><TD>R-CEL-110312</TD><TD>12</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.636e-02</TD><TD>-3.64</TD><TD>Mitophagy</TD><TD>REACTOME pathways</TD><TD>R-CEL-5205647</TD><TD>12</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.636e-02</TD><TD>-3.64</TD><TD>Pink/Parkin Mediated Mitophagy</TD><TD>REACTOME pathways</TD><TD>R-CEL-5205685</TD><TD>12</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.646e-02</TD><TD>-3.63</TD><TD>Alkaline_phosphatase_core_sf</TD><TD>interpro domains</TD><TD>IPR017850</TD><TD>19</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>Y73F8A.35</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>GCACCTT_MIR18A_MIR18B</TD><TD>MSigDB lists</TD><TD>GCACCTT_MIR18A_MIR18B</TD><TD>19</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>GO_HORMONE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_HORMONE_BINDING</TD><TD>19</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN</TD><TD>MSigDB lists</TD><TD>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN</TD><TD>19</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</TD><TD>MSigDB lists</TD><TD>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</TD><TD>19</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>GRE_C</TD><TD>MSigDB lists</TD><TD>GRE_C</TD><TD>19</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>2.672e-02</TD><TD>-3.62</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_UNSTIM_VS_8H_LPS_DC_DN</TD><TD>19</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.678e-02</TD><TD>-3.62</TD><TD>axon</TD><TD>cellular component</TD><TD>GO:0030424</TD><TD>200</TD><TD>2</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3,gcy-28</TD></TR>
<TR><TD>2.682e-02</TD><TD>-3.62</TD><TD>cell-cell adherens junction</TD><TD>cellular component</TD><TD>GO:0005913</TD><TD>21</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>afd-1</TD></TR>
<TR><TD>2.757e-02</TD><TD>-3.59</TD><TD>JMJC</TD><TD>prosite domains</TD><TD>PS51184</TD><TD>14</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.757e-02</TD><TD>-3.59</TD><TD>PAW</TD><TD>prosite domains</TD><TD>PS51398</TD><TD>14</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>2.759e-02</TD><TD>-3.59</TD><TD>regulation of receptor-mediated endocytosis</TD><TD>biological process</TD><TD>GO:0048259</TD><TD>16</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.759e-02</TD><TD>-3.59</TD><TD>demethylation</TD><TD>biological process</TD><TD>GO:0070988</TD><TD>16</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>jmjd-3.3</TD></TR>
<TR><TD>2.759e-02</TD><TD>-3.59</TD><TD>lysosomal transport</TD><TD>biological process</TD><TD>GO:0007041</TD><TD>16</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>2.783e-02</TD><TD>-3.58</TD><TD>Rab-GTPase_TBC_sf</TD><TD>interpro domains</TD><TD>IPR035969</TD><TD>20</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.783e-02</TD><TD>-3.58</TD><TD>Rab-GTPase-TBC_dom</TD><TD>interpro domains</TD><TD>IPR000195</TD><TD>20</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>NAKAMURA_CANCER_MICROENVIRONMENT_DN</TD><TD>MSigDB lists</TD><TD>NAKAMURA_CANCER_MICROENVIRONMENT_DN</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>LEE_DIFFERENTIATING_T_LYMPHOCYTE</TD><TD>MSigDB lists</TD><TD>LEE_DIFFERENTIATING_T_LYMPHOCYTE</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</TD><TD>MSigDB lists</TD><TD>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN</TD><TD>MSigDB lists</TD><TD>GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</TD><TD>MSigDB lists</TD><TD>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>LEF1_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>LEF1_UP.V1_UP</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>2.811e-02</TD><TD>-3.57</TD><TD>GERY_CEBP_TARGETS</TD><TD>MSigDB lists</TD><TD>GERY_CEBP_TARGETS</TD><TD>20</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.837e-02</TD><TD>-3.56</TD><TD>GO_SINGLE_ORGANISM_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_SINGLE_ORGANISM_BIOSYNTHETIC_PROCESS</TD><TD>541</TD><TD>3</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,gcy-28,F26H9.5</TD></TR>
<TR><TD>2.852e-02</TD><TD>-3.56</TD><TD>Negative regulation of MET activity</TD><TD>REACTOME pathways</TD><TD>R-CEL-6807004</TD><TD>13</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>2.868e-02</TD><TD>-3.55</TD><TD>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</TD><TD>MSigDB lists</TD><TD>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</TD><TD>200</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>2.906e-02</TD><TD>-3.54</TD><TD>cell junction</TD><TD>cellular component</TD><TD>GO:0030054</TD><TD>209</TD><TD>2</TD><TD>11604</TD><TD>15</TD>
<TD>toca-1,afd-1</TD></TR>
<TR><TD>2.929e-02</TD><TD>-3.53</TD><TD>fatty acid elongation</TD><TD>biological process</TD><TD>GO:0030497</TD><TD>17</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.929e-02</TD><TD>-3.53</TD><TD>serine family amino acid biosynthetic process</TD><TD>biological process</TD><TD>GO:0009070</TD><TD>17</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.934e-02</TD><TD>-3.53</TD><TD>Glycine, serine and threonine metabolism</TD><TD>KEGG pathways</TD><TD>ko00260</TD><TD>27</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.934e-02</TD><TD>-3.53</TD><TD>Glycine, serine and threonine metabolism</TD><TD>KEGG pathways</TD><TD>cel00260</TD><TD>27</TD><TD>1</TD><TD>2735</TD><TD>3</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.945e-02</TD><TD>-3.53</TD><TD>RabGAP-TBC</TD><TD>pfam domains</TD><TD>PF00566</TD><TD>20</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.950e-02</TD><TD>-3.52</TD><TD>WALLACE_PROSTATE_CANCER_RACE_DN</TD><TD>MSigDB lists</TD><TD>WALLACE_PROSTATE_CANCER_RACE_DN</TD><TD>21</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>2.950e-02</TD><TD>-3.52</TD><TD>HELLER_SILENCED_BY_METHYLATION_DN</TD><TD>MSigDB lists</TD><TD>HELLER_SILENCED_BY_METHYLATION_DN</TD><TD>21</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.950e-02</TD><TD>-3.52</TD><TD>PEREZ_TP53_AND_TP63_TARGETS</TD><TD>MSigDB lists</TD><TD>PEREZ_TP53_AND_TP63_TARGETS</TD><TD>21</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>2.950e-02</TD><TD>-3.52</TD><TD>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</TD><TD>MSigDB lists</TD><TD>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</TD><TD>21</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>2.950e-02</TD><TD>-3.52</TD><TD>ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION</TD><TD>MSigDB lists</TD><TD>ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION</TD><TD>21</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.012e-02</TD><TD>-3.50</TD><TD>hgrs-1 (Hepatocyte Growth factor-Regulated TK Substrate (HRS) family)</TD><TD>protein interactions</TD><TD>177617</TD><TD>24</TD><TD>1</TD><TD>3938</TD><TD>5</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.069e-02</TD><TD>-3.48</TD><TD>Activation of gene expression by SREBF (SREBP)</TD><TD>REACTOME pathways</TD><TD>R-CEL-2426168</TD><TD>14</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GO_COATED_PIT</TD><TD>MSigDB lists</TD><TD>GO_COATED_PIT</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>LE_EGR2_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>LE_EGR2_TARGETS_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN</TD><TD>MSigDB lists</TD><TD>GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</TD><TD>MSigDB lists</TD><TD>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>REACTOME_TRIGLYCERIDE_BIOSYNTHESIS</TD><TD>MSigDB lists</TD><TD>REACTOME_TRIGLYCERIDE_BIOSYNTHESIS</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>NRL_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>NRL_DN.V1_UP</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>ACAGGGT_MIR10A_MIR10B</TD><TD>MSigDB lists</TD><TD>ACAGGGT_MIR10A_MIR10B</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN</TD><TD>MSigDB lists</TD><TD>GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>EPPERT_HSC_R</TD><TD>MSigDB lists</TD><TD>EPPERT_HSC_R</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.089e-02</TD><TD>-3.48</TD><TD>GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN</TD><TD>22</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.099e-02</TD><TD>-3.47</TD><TD>organelle transport along microtubule</TD><TD>biological process</TD><TD>GO:0072384</TD><TD>18</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>3.194e-02</TD><TD>-3.44</TD><TD>SMAD_FHA_dom_sf</TD><TD>interpro domains</TD><TD>IPR008984</TD><TD>23</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>afd-1</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</TD><TD>MSigDB lists</TD><TD>PODAR_RESPONSE_TO_ADAPHOSTIN_UP</TD><TD>23</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>GSE27786_NKCELL_VS_ERYTHROBLAST_DN</TD><TD>MSigDB lists</TD><TD>GSE27786_NKCELL_VS_ERYTHROBLAST_DN</TD><TD>23</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP</TD><TD>23</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN</TD><TD>23</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>SANSOM_APC_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>SANSOM_APC_TARGETS_UP</TD><TD>23</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.227e-02</TD><TD>-3.43</TD><TD>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</TD><TD>MSigDB lists</TD><TD>KAN_RESPONSE_TO_ARSENIC_TRIOXIDE</TD><TD>23</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.311e-02</TD><TD>-3.41</TD><TD>axon part</TD><TD>cellular component</TD><TD>GO:0033267</TD><TD>26</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>3.366e-02</TD><TD>-3.39</TD><TD>IPF1_Q4</TD><TD>MSigDB lists</TD><TD>IPF1_Q4</TD><TD>24</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.366e-02</TD><TD>-3.39</TD><TD>GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP</TD><TD>MSigDB lists</TD><TD>GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP</TD><TD>24</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.366e-02</TD><TD>-3.39</TD><TD>GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN</TD><TD>24</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.366e-02</TD><TD>-3.39</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE2706_2H_VS_8H_R848_STIM_DC_DN</TD><TD>24</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.371e-02</TD><TD>-3.39</TD><TD>Proteasome Degradation</TD><TD>WikiPathways</TD><TD>WP470</TD><TD>36</TD><TD>1</TD><TD>1068</TD><TD>1</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.373e-02</TD><TD>-3.39</TD><TD>ONKEN_UVEAL_MELANOMA_UP</TD><TD>MSigDB lists</TD><TD>ONKEN_UVEAL_MELANOMA_UP</TD><TD>218</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1,elo-3</TD></TR>
<TR><TD>3.437e-02</TD><TD>-3.37</TD><TD>glycoprotein catabolic process</TD><TD>biological process</TD><TD>GO:0006516</TD><TD>20</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>3.437e-02</TD><TD>-3.37</TD><TD>protein deglycosylation</TD><TD>biological process</TD><TD>GO:0006517</TD><TD>20</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>3.437e-02</TD><TD>-3.37</TD><TD>synaptic vesicle transport</TD><TD>biological process</TD><TD>GO:0048489</TD><TD>20</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>3.501e-02</TD><TD>-3.35</TD><TD>EGFR downregulation</TD><TD>REACTOME pathways</TD><TD>R-CEL-182971</TD><TD>16</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.501e-02</TD><TD>-3.35</TD><TD>Signaling by PTK6</TD><TD>REACTOME pathways</TD><TD>R-CEL-8848021</TD><TD>16</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP</TD><TD>MSigDB lists</TD><TD>GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP</TD><TD>25</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>WIERENGA_STAT5A_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>WIERENGA_STAT5A_TARGETS_UP</TD><TD>25</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</TD><TD>MSigDB lists</TD><TD>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN</TD><TD>25</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>MODULE_342</TD><TD>MSigDB lists</TD><TD>MODULE_342</TD><TD>25</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>CSR_LATE_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>CSR_LATE_UP.V1_DN</TD><TD>25</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.504e-02</TD><TD>-3.35</TD><TD>PKCA_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>PKCA_DN.V1_DN</TD><TD>25</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>LTE2_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>LTE2_UP.V1_DN</TD><TD>26</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>GO_REGULATION_OF_BLOOD_PRESSURE</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_BLOOD_PRESSURE</TD><TD>26</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN</TD><TD>26</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>FOXO1_01</TD><TD>MSigDB lists</TD><TD>FOXO1_01</TD><TD>26</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.642e-02</TD><TD>-3.31</TD><TD>GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP</TD><TD>26</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.668e-02</TD><TD>-3.31</TD><TD>SH3_1</TD><TD>pfam domains</TD><TD>PF00018</TD><TD>25</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.668e-02</TD><TD>-3.31</TD><TD>ubiquitin</TD><TD>pfam domains</TD><TD>PF00240</TD><TD>25</TD><TD>1</TD><TD>12733</TD><TD>19</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.690e-02</TD><TD>-3.30</TD><TD>Signaling by GPCR</TD><TD>REACTOME pathways</TD><TD>R-CEL-372790</TD><TD>143</TD><TD>2</TD><TD>3154</TD><TD>7</TD>
<TD>rog-1,ubq-1</TD></TR>
<TR><TD>3.690e-02</TD><TD>-3.30</TD><TD>cell projection part</TD><TD>cellular component</TD><TD>GO:0044463</TD><TD>238</TD><TD>2</TD><TD>11604</TD><TD>15</TD>
<TD>gcy-28,apd-3</TD></TR>
<TR><TD>3.690e-02</TD><TD>-3.30</TD><TD>plasma membrane bounded cell projection part</TD><TD>cellular component</TD><TD>GO:0120038</TD><TD>238</TD><TD>2</TD><TD>11604</TD><TD>15</TD>
<TD>gcy-28,apd-3</TD></TR>
<TR><TD>3.699e-02</TD><TD>-3.30</TD><TD>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</TD><TD>MSigDB lists</TD><TD>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</TD><TD>229</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5,elo-3</TD></TR>
<TR><TD>3.716e-02</TD><TD>-3.29</TD><TD>Regulation of cholesterol biosynthesis by SREBP (SREBF)</TD><TD>REACTOME pathways</TD><TD>R-CEL-1655829</TD><TD>17</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.773e-02</TD><TD>-3.28</TD><TD>TBC</TD><TD>smart domains</TD><TD>SM00164</TD><TD>19</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.775e-02</TD><TD>-3.28</TD><TD>activation of GTPase activity</TD><TD>biological process</TD><TD>GO:0090630</TD><TD>22</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION</TD><TD>MSigDB lists</TD><TD>KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GO_BONE_DEVELOPMENT</TD><TD>MSigDB lists</TD><TD>GO_BONE_DEVELOPMENT</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>RB_P130_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>RB_P130_DN.V1_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.780e-02</TD><TD>-3.28</TD><TD>GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP</TD><TD>MSigDB lists</TD><TD>GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP</TD><TD>27</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>3.876e-02</TD><TD>-3.25</TD><TD>A/G_cyclase_CS</TD><TD>interpro domains</TD><TD>IPR018297</TD><TD>28</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.917e-02</TD><TD>-3.24</TD><TD>TBC_RABGAP</TD><TD>prosite domains</TD><TD>PS50086</TD><TD>20</TD><TD>1</TD><TD>7024</TD><TD>14</TD>
<TD>tbc-6</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP</TD><TD>28</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP</TD><TD>28</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN</TD><TD>MSigDB lists</TD><TD>GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN</TD><TD>28</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>AREB6_04</TD><TD>MSigDB lists</TD><TD>AREB6_04</TD><TD>28</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.918e-02</TD><TD>-3.24</TD><TD>GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN</TD><TD>28</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>3.931e-02</TD><TD>-3.24</TD><TD>alpha-linolenic (omega3) and linoleic (omega6) acid metabolism</TD><TD>REACTOME pathways</TD><TD>R-CEL-2046104</TD><TD>18</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.931e-02</TD><TD>-3.24</TD><TD>alpha-linolenic acid (ALA) metabolism</TD><TD>REACTOME pathways</TD><TD>R-CEL-2046106</TD><TD>18</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.931e-02</TD><TD>-3.24</TD><TD>Translesion Synthesis by POLH</TD><TD>REACTOME pathways</TD><TD>R-CEL-110320</TD><TD>18</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>3.931e-02</TD><TD>-3.24</TD><TD>Synthesis of very long-chain fatty acyl-CoAs</TD><TD>REACTOME pathways</TD><TD>R-CEL-75876</TD><TD>18</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>elo-3</TD></TR>
<TR><TD>3.944e-02</TD><TD>-3.23</TD><TD>GO_MOLECULAR_FUNCTION_REGULATOR</TD><TD>MSigDB lists</TD><TD>GO_MOLECULAR_FUNCTION_REGULATOR</TD><TD>237</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1,tbc-6</TD></TR>
<TR><TD>4.037e-02</TD><TD>-3.21</TD><TD>GO_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS</TD><TD>240</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP</TD><TD>MSigDB lists</TD><TD>GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN</TD><TD>MSigDB lists</TD><TD>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>GSE4142_NAIVE_VS_GC_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE4142_NAIVE_VS_GC_BCELL_UP</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>BHATTACHARYA_EMBRYONIC_STEM_CELL</TD><TD>MSigDB lists</TD><TD>BHATTACHARYA_EMBRYONIC_STEM_CELL</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN</TD><TD>MSigDB lists</TD><TD>GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>MARKEY_RB1_CHRONIC_LOF_UP</TD><TD>MSigDB lists</TD><TD>MARKEY_RB1_CHRONIC_LOF_UP</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>CRX_NRL_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>CRX_NRL_DN.V1_UP</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>GENTILE_UV_LOW_DOSE_DN</TD><TD>MSigDB lists</TD><TD>GENTILE_UV_LOW_DOSE_DN</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.055e-02</TD><TD>-3.21</TD><TD>GO_FATTY_ACYL_COA_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_FATTY_ACYL_COA_METABOLIC_PROCESS</TD><TD>29</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.100e-02</TD><TD>-3.19</TD><TD>GO_REGULATION_OF_HYDROLASE_ACTIVITY</TD><TD>MSigDB lists</TD><TD>GO_REGULATION_OF_HYDROLASE_ACTIVITY</TD><TD>242</TD><TD>2</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1,tbc-6</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>ER Quality Control Compartment (ERQC)</TD><TD>REACTOME pathways</TD><TD>R-CEL-901032</TD><TD>19</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>DNA Damage Bypass</TD><TD>REACTOME pathways</TD><TD>R-CEL-73893</TD><TD>19</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template</TD><TD>REACTOME pathways</TD><TD>R-CEL-110313</TD><TD>19</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.145e-02</TD><TD>-3.18</TD><TD>Endosomal Sorting Complex Required For Transport (ESCRT)</TD><TD>REACTOME pathways</TD><TD>R-CEL-917729</TD><TD>19</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>GO_THIOESTER_BIOSYNTHETIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_THIOESTER_BIOSYNTHETIC_PROCESS</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN</TD><TD>MSigDB lists</TD><TD>GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>MSigDB lists</TD><TD>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>CTCTGGA_MIR520A_MIR525</TD><TD>MSigDB lists</TD><TD>CTCTGGA_MIR520A_MIR525</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>SWEET_KRAS_ONCOGENIC_SIGNATURE</TD><TD>MSigDB lists</TD><TD>SWEET_KRAS_ONCOGENIC_SIGNATURE</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>GSE24210_TCONV_VS_TREG_UP</TD><TD>MSigDB lists</TD><TD>GSE24210_TCONV_VS_TREG_UP</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>PR_Q2</TD><TD>MSigDB lists</TD><TD>PR_Q2</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.193e-02</TD><TD>-3.17</TD><TD>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</TD><TD>MSigDB lists</TD><TD>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</TD><TD>30</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>regulation of development, heterochronic</TD><TD>biological process</TD><TD>GO:0040034</TD><TD>25</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>4.279e-02</TD><TD>-3.15</TD><TD>synaptic vesicle localization</TD><TD>biological process</TD><TD>GO:0097479</TD><TD>25</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>4.309e-02</TD><TD>-3.14</TD><TD>recycling endosome</TD><TD>cellular component</TD><TD>GO:0055037</TD><TD>34</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.320e-02</TD><TD>-3.14</TD><TD>small molecule biosynthetic process</TD><TD>biological process</TD><TD>GO:0044283</TD><TD>192</TD><TD>2</TD><TD>9166</TD><TD>16</TD>
<TD>elo-3,F26H9.5</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>SANSOM_APC_TARGETS</TD><TD>MSigDB lists</TD><TD>SANSOM_APC_TARGETS</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>GSE17721_CTRL_VS_LPS_4H_BMDC_DN</TD><TD>MSigDB lists</TD><TD>GSE17721_CTRL_VS_LPS_4H_BMDC_DN</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>GSE27786_LSK_VS_LIN_NEG_CELL_UP</TD><TD>MSigDB lists</TD><TD>GSE27786_LSK_VS_LIN_NEG_CELL_UP</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>WILCOX_RESPONSE_TO_PROGESTERONE_UP</TD><TD>MSigDB lists</TD><TD>WILCOX_RESPONSE_TO_PROGESTERONE_UP</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>GSE7852_LN_VS_FAT_TREG_DN</TD><TD>MSigDB lists</TD><TD>GSE7852_LN_VS_FAT_TREG_DN</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>MEK_UP.V1_DN</TD><TD>MSigDB lists</TD><TD>MEK_UP.V1_DN</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP</TD><TD>MSigDB lists</TD><TD>GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.330e-02</TD><TD>-3.14</TD><TD>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</TD><TD>MSigDB lists</TD><TD>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</TD><TD>31</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.418e-02</TD><TD>-3.12</TD><TD>AH/BAR_dom_sf</TD><TD>interpro domains</TD><TD>IPR027267</TD><TD>32</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.447e-02</TD><TD>-3.11</TD><TD>receptor guanylyl cyclase signaling pathway</TD><TD>biological process</TD><TD>GO:0007168</TD><TD>26</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.447e-02</TD><TD>-3.11</TD><TD>nucleosome assembly</TD><TD>biological process</TD><TD>GO:0006334</TD><TD>26</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>hil-8</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>CDC5_01</TD><TD>MSigDB lists</TD><TD>CDC5_01</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP</TD><TD>MSigDB lists</TD><TD>GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>TAL1BETAE47_01</TD><TD>MSigDB lists</TD><TD>TAL1BETAE47_01</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</TD><TD>MSigDB lists</TD><TD>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>FOXO3_01</TD><TD>MSigDB lists</TD><TD>FOXO3_01</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</TD><TD>MSigDB lists</TD><TD>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>UDAYAKUMAR_MED1_TARGETS_UP</TD><TD>MSigDB lists</TD><TD>UDAYAKUMAR_MED1_TARGETS_UP</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN</TD><TD>MSigDB lists</TD><TD>GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>MTOR_UP.V1_UP</TD><TD>MSigDB lists</TD><TD>MTOR_UP.V1_UP</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.467e-02</TD><TD>-3.11</TD><TD>GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN</TD><TD>MSigDB lists</TD><TD>GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN</TD><TD>32</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.557e-02</TD><TD>-3.09</TD><TD>membrane coat</TD><TD>cellular component</TD><TD>GO:0030117</TD><TD>36</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>4.557e-02</TD><TD>-3.09</TD><TD>coated membrane</TD><TD>cellular component</TD><TD>GO:0048475</TD><TD>36</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>4.573e-02</TD><TD>-3.09</TD><TD>Negative regulation of MAPK pathway</TD><TD>REACTOME pathways</TD><TD>R-CEL-5675221</TD><TD>21</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>CRX_DN.V1_UP</TD><TD>MSigDB lists</TD><TD>CRX_DN.V1_UP</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN</TD><TD>MSigDB lists</TD><TD>GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP</TD><TD>MSigDB lists</TD><TD>GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>AKT_UP_MTOR_DN.V1_DN</TD><TD>MSigDB lists</TD><TD>AKT_UP_MTOR_DN.V1_DN</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>GO_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS</TD><TD>MSigDB lists</TD><TD>GO_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.604e-02</TD><TD>-3.08</TD><TD>GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP</TD><TD>MSigDB lists</TD><TD>GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP</TD><TD>33</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.606e-02</TD><TD>-3.08</TD><TD>-</TD><TD>gene3d domains</TD><TD>1.20.1270.60</TD><TD>32</TD><TD>1</TD><TD>5448</TD><TD>8</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.614e-02</TD><TD>-3.08</TD><TD>positive regulation of oviposition</TD><TD>biological process</TD><TD>GO:1901046</TD><TD>27</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.614e-02</TD><TD>-3.08</TD><TD>protein quality control for misfolded or incompletely synthesized proteins</TD><TD>biological process</TD><TD>GO:0006515</TD><TD>27</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>T20D4.5</TD></TR>
<TR><TD>4.623e-02</TD><TD>-3.07</TD><TD>guanylate cyclase activity</TD><TD>molecular function</TD><TD>GO:0004383</TD><TD>34</TD><TD>1</TD><TD>9362</TD><TD>13</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.688e-02</TD><TD>-3.06</TD><TD>PyrdxlP-dep_Trfase_dom1</TD><TD>interpro domains</TD><TD>IPR015422</TD><TD>34</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN</TD><TD>MSigDB lists</TD><TD>GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</TD><TD>MSigDB lists</TD><TD>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP</TD><TD>MSigDB lists</TD><TD>GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>TAL1BETAITF2_01</TD><TD>MSigDB lists</TD><TD>TAL1BETAITF2_01</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>gcy-28</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>IGARASHI_ATF4_TARGETS_DN</TD><TD>MSigDB lists</TD><TD>IGARASHI_ATF4_TARGETS_DN</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.741e-02</TD><TD>-3.05</TD><TD>CREBP1_01</TD><TD>MSigDB lists</TD><TD>CREBP1_01</TD><TD>34</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.781e-02</TD><TD>-3.04</TD><TD>regulation of Notch signaling pathway</TD><TD>biological process</TD><TD>GO:0008593</TD><TD>28</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>4.781e-02</TD><TD>-3.04</TD><TD>post-Golgi vesicle-mediated transport</TD><TD>biological process</TD><TD>GO:0006892</TD><TD>28</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>apd-3</TD></TR>
<TR><TD>4.781e-02</TD><TD>-3.04</TD><TD>chromatin assembly</TD><TD>biological process</TD><TD>GO:0031497</TD><TD>28</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>hil-8</TD></TR>
<TR><TD>4.781e-02</TD><TD>-3.04</TD><TD>embryonic digestive tract morphogenesis</TD><TD>biological process</TD><TD>GO:0048557</TD><TD>28</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.786e-02</TD><TD>-3.04</TD><TD>ISG15 antiviral mechanism</TD><TD>REACTOME pathways</TD><TD>R-CEL-1169408</TD><TD>22</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.786e-02</TD><TD>-3.04</TD><TD>Protein ubiquitination</TD><TD>REACTOME pathways</TD><TD>R-CEL-8852135</TD><TD>22</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.786e-02</TD><TD>-3.04</TD><TD>Antiviral mechanism by IFN-stimulated genes</TD><TD>REACTOME pathways</TD><TD>R-CEL-1169410</TD><TD>22</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.786e-02</TD><TD>-3.04</TD><TD>Synthesis of active ubiquitin: roles of E1 and E2 enzymes</TD><TD>REACTOME pathways</TD><TD>R-CEL-8866652</TD><TD>22</TD><TD>1</TD><TD>3154</TD><TD>7</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.822e-02</TD><TD>-3.03</TD><TD>Ubiquitin_dom</TD><TD>interpro domains</TD><TD>IPR000626</TD><TD>35</TD><TD>1</TD><TD>14190</TD><TD>20</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GO_RAB_GTPASE_BINDING</TD><TD>MSigDB lists</TD><TD>GO_RAB_GTPASE_BINDING</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>tbc-6</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN</TD><TD>MSigDB lists</TD><TD>GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN</TD><TD>MSigDB lists</TD><TD>GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>MORI_PRE_BI_LYMPHOCYTE_UP</TD><TD>MSigDB lists</TD><TD>MORI_PRE_BI_LYMPHOCYTE_UP</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE11057_CD4_CENT_MEM_VS_PBMC_UP</TD><TD>MSigDB lists</TD><TD>GSE11057_CD4_CENT_MEM_VS_PBMC_UP</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>SHEPARD_BMYB_MORPHOLINO_DN</TD><TD>MSigDB lists</TD><TD>SHEPARD_BMYB_MORPHOLINO_DN</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>SREBP_Q3</TD><TD>MSigDB lists</TD><TD>SREBP_Q3</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>toca-1</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP</TD><TD>MSigDB lists</TD><TD>GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN</TD><TD>MSigDB lists</TD><TD>GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.878e-02</TD><TD>-3.02</TD><TD>GSE3982_BCELL_VS_TH1_DN</TD><TD>MSigDB lists</TD><TD>GSE3982_BCELL_VS_TH1_DN</TD><TD>35</TD><TD>1</TD><TD>3519</TD><TD>5</TD>
<TD>elo-3</TD></TR>
<TR><TD>4.888e-02</TD><TD>-3.02</TD><TD>-</TD><TD>gene3d domains</TD><TD>3.90.1150.10</TD><TD>34</TD><TD>1</TD><TD>5448</TD><TD>8</TD>
<TD>F26H9.5</TD></TR>
<TR><TD>4.905e-02</TD><TD>-3.01</TD><TD>chromatin organization</TD><TD>biological process</TD><TD>GO:0006325</TD><TD>206</TD><TD>2</TD><TD>9166</TD><TD>16</TD>
<TD>hil-8,jmjd-3.3</TD></TR>
<TR><TD>4.927e-02</TD><TD>-3.01</TD><TD>plasma membrane bounded cell projection cytoplasm</TD><TD>cellular component</TD><TD>GO:0032838</TD><TD>39</TD><TD>1</TD><TD>11604</TD><TD>15</TD>
<TD>apd-3</TD></TR>
<TR><TD>4.938e-02</TD><TD>-3.01</TD><TD>UBQ</TD><TD>smart domains</TD><TD>SM00213</TD><TD>25</TD><TD>1</TD><TD>5448</TD><TD>11</TD>
<TD>ubq-1</TD></TR>
<TR><TD>4.948e-02</TD><TD>-3.01</TD><TD>regulation of mesoderm formation</TD><TD>biological process</TD><TD>GO:1905902</TD><TD>29</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>4.948e-02</TD><TD>-3.01</TD><TD>regulation of mesoderm development</TD><TD>biological process</TD><TD>GO:2000380</TD><TD>29</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>4.948e-02</TD><TD>-3.01</TD><TD>regulation of mesodermal cell differentiation</TD><TD>biological process</TD><TD>GO:1905770</TD><TD>29</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
<TR><TD>4.948e-02</TD><TD>-3.01</TD><TD>regulation of mesodermal cell fate specification</TD><TD>biological process</TD><TD>GO:0042661</TD><TD>29</TD><TD>1</TD><TD>9166</TD><TD>16</TD>
<TD>sel-7</TD></TR>
</TABLE>
</BODY></HTML>
